These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 33900855)
1. Kidney hemodynamic function in men and postmenopausal women with type 2 diabetes and preserved kidney function. van Velzen DM; Smits MM; van Bommel EJM; Muskiet MHA; Tonneijck L; Kramer MHH; Joles JA; den Heijer M; Nokoff N; Bjornstad P; van Raalte DH Am J Physiol Renal Physiol; 2021 Jun; 320(6):F1152-F1158. PubMed ID: 33900855 [TBL] [Abstract][Full Text] [Related]
2. Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial. Tonneijck L; Smits MM; Muskiet MHA; Hoekstra T; Kramer MHH; Danser AHJ; Diamant M; Joles JA; van Raalte DH Diabetologia; 2016 Jul; 59(7):1412-1421. PubMed ID: 27038451 [TBL] [Abstract][Full Text] [Related]
3. Insulin Sensitivity and Renal Hemodynamic Function in Metformin-Treated Adults With Type 2 Diabetes and Preserved Renal Function. van Bommel EJM; Ruiter D; Muskiet MHA; van Baar MJB; Kramer MHH; Nieuwdorp M; Joles JA; Bjornstad P; van Raalte DH Diabetes Care; 2020 Jan; 43(1):228-234. PubMed ID: 31662305 [TBL] [Abstract][Full Text] [Related]
4. Influence of sex on hyperfiltration in patients with uncomplicated type 1 diabetes. Škrtić M; Lytvyn Y; Bjornstad P; Reich HN; Scholey JW; Yip P; Sochett EB; Perkins B; Cherney DZ Am J Physiol Renal Physiol; 2017 Apr; 312(4):F599-F606. PubMed ID: 28031170 [TBL] [Abstract][Full Text] [Related]
5. Plasma uric acid and renal haemodynamics in type 2 diabetes patients. Suijk DL; Smits MM; Muskiet MH; Tonneijck L; Kramer MH; Joles JA; van Raalte DH Nephrology (Carlton); 2020 Apr; 25(4):290-297. PubMed ID: 31429150 [TBL] [Abstract][Full Text] [Related]
6. Renal Hemodynamic Function and RAAS Activation Over the Natural History of Type 1 Diabetes. Lytvyn Y; Bjornstad P; Lovshin JA; Boulet G; Farooqi MA; Lai V; Tse J; Cham L; Lovblom LE; Weisman A; Keenan HA; Brent MH; Paul N; Bril V; Advani A; Sochett E; Perkins BA; Cherney DZI Am J Kidney Dis; 2019 Jun; 73(6):786-796. PubMed ID: 30799029 [TBL] [Abstract][Full Text] [Related]
7. Postprandial renal haemodynamic effect of lixisenatide vs once-daily insulin-glulisine in patients with type 2 diabetes on insulin-glargine: An 8-week, randomised, open-label trial. Tonneijck L; Muskiet MHA; Smits MM; Hoekstra T; Kramer MHH; Danser AHJ; Diamant M; Joles JA; van Raalte DH Diabetes Obes Metab; 2017 Dec; 19(12):1669-1680. PubMed ID: 28449402 [TBL] [Abstract][Full Text] [Related]
8. Impact of gender on the renal response to angiotensin II. Miller JA; Anacta LA; Cattran DC Kidney Int; 1999 Jan; 55(1):278-85. PubMed ID: 9893137 [TBL] [Abstract][Full Text] [Related]
9. Glomerular resistances predict long-term GFR decline in type 2 diabetic patients without overt nephropathy: a longitudinal subgroup analysis of the DEMAND trial. Carrara F; Ruggenenti P; Perna A; Iliev IP; Gaspari F; Ferrari S; Stucchi N; Bossi A; Trevisan R; Remuzzi G; Parvanova A Acta Diabetol; 2022 Mar; 59(3):309-317. PubMed ID: 34648087 [TBL] [Abstract][Full Text] [Related]
10. The relationships between markers of tubular injury and intrarenal haemodynamic function in adults with and without type 1 diabetes: Results from the Canadian Study of Longevity in Type 1 Diabetes. Bjornstad P; Singh SK; Snell-Bergeon JK; Lovshin JA; Lytvyn Y; Lovblom LE; Rewers MJ; Boulet G; Lai V; Tse J; Cham L; Orszag A; Weisman A; Keenan HA; Brent MH; Paul N; Bril V; Perkins BA; Cherney DZI Diabetes Obes Metab; 2019 Mar; 21(3):575-583. PubMed ID: 30311395 [TBL] [Abstract][Full Text] [Related]
11. Marked association between obesity and glomerular hyperfiltration: a cross-sectional study in an African population. Wuerzner G; Pruijm M; Maillard M; Bovet P; Renaud C; Burnier M; Bochud M Am J Kidney Dis; 2010 Aug; 56(2):303-12. PubMed ID: 20538392 [TBL] [Abstract][Full Text] [Related]
12. Body mass index is associated with altered renal hemodynamics in non-obese healthy subjects. Bosma RJ; van der Heide JJ; Oosterop EJ; de Jong PE; Navis G Kidney Int; 2004 Jan; 65(1):259-65. PubMed ID: 14675058 [TBL] [Abstract][Full Text] [Related]
13. Perirenal fat and chronic kidney disease in type 2 diabetes: The mediation role of afferent arteriolar resistance. Chen X; Qin Y; Hu J; Shen Y; Mao Y; Xie L; Li J; Wang J; Yang S; Li Q; He JC; Wang Z Diabetes Metab; 2024 Nov; 50(6):101583. PubMed ID: 39389218 [TBL] [Abstract][Full Text] [Related]